Elevated polyclonal serum immunoglobulin free light chains ( FLCs ; combined FLC+FLC [ cFLC ] ) are associated with adverse clinical outcomes and increased mortality ; we investigated cFLC and cardiovascular disease ( CVD ) events in type 2 diabetes .